p8 is a stress-induced DNA-binding protein, biochemically related to the architectural chromatin binding HMG protein family and whose function is presently unknown. We obtained ®broblast from mice lacking p8 and found that p8 is involved in cell growth regulation and in apoptosis. p8 7/7 mouse embryonic ®broblasts (MEFs) grow more rapidly than p8 +/+ MEFs. This might be explained by the higher intracellular level and activity of the Cdk2 and Cdk4 observed in p8 7/7 MEFs, which in turn may result, at least in part, from the concomitant decrease observed in the amount of cyclindependent kinase inhibitor p27. We also report that p8 mRNA expression is strongly activated in ®broblasts after cell growth arrest induced by serum deprivation or con¯uence. As expected, MEFs expressing p8 arrest their growth more rapidly after serum deprivation than MEFs lacking p8, which strongly suggests that p8 overexpression is implicated in cell growth arrest. On the other hand, p8 +/+ MEFs are more sensitive than p8
Introduction
While studying the molecular response of the injured acinar cell of the pancreas, we identi®ed a new gene, called p8, whose expression is strongly induced during the acute phase of pancreatitis (Mallo et al., 1997) . Further experiments have shown that p8 activation is not restricted to pancreatic cells. In vivo, p8 mRNA is activated in several tissues in response to systemic LPS (Jiang et al., 1999) and in vitro studies showed that a variety of cell lines exhibited transient p8 mRNA expression in response to stress (Mallo et al., 1997; Vasseur et al., 1999a) . p8 is therefore a ubiquitous protein induced by cellular stress. Concomitant studies by another laboratory (Ree et al., 1999) revealed that expression of the candidate of metastasis 1 (Com 1) protein, which is identical to human p8 (Vasseur et al., 1999a) , mediates the growth of tumor cells after metastatic establishment in a secondary organ, indicating that activated expression of p8 in metastatic cells is required for tumor progression. In fact, overexpression of p8 in certain cell lines promotes growth (Mallo et al., 1997; Vasseur et al., 1999a) but it can also inhibit growth when recruited by inhibitory signals (Bratland et al., 2000) . Taken together, these results suggest that p8 expression may regulate many cellular functions, in response to cellular injury or during tumor development, and that p8 may play a dierent role depending on the cell type and/or growth conditions. Analysis of p8 primary structure suggested that it should be a DNA-binding protein (Mallo et al., 1997; Ree et al., 1999) . Supporting this hypothesis we detected p8 within the nucleus of Cos-7 cells transfected with a p8 expression plasmid, although it was also partly located to the cytoplasm (Vasseur et al., 1999a) . More recently, we performed biochemical and biophysical studies showing that human recombinant p8 was in many structural aspects very similar to the`high mobility group' (HMG) proteins, although sharing with them low amino acid sequence homology. In addition, p8 binding to DNA, rather weak with the native protein, was strongly enhanced after phosphorylation by PKA on serine/threonine residues (Encinar et al., 2001) . HMG protein binding to DNA is also regulated by post-translational modi®cations. Thus, in spite of a lack of signi®cant sequence homology, p8 can be considered as a HMG-like protein.
In response to stress agents, cells activate various intracytoplasmic pathways, depending on cell type and nature of the agent (reviewed in Allen and Tresini, 2000; Garrington and Johnson, 1999; Goldschmidt-Clermont and Moldovan, 1999; Ichijo, 1999; Kaufman, 1999; Schulze-Ostho et al., 1998; Shackel-ford et al., 1999; Stronach and Perrimon, 1999) , that eventually reach the nucleus to modulate gene expression. By regulating genomic response, these stress-associated pathways will determine whether a cell re-enters the cell cycle, undergoes cell cycle arrest or enters a cell-death program (reviewed in Utz and Anderson, 2000; Wang et al., 1999) . Consequently, involvement of stress-activated genes in these essential functions is very likely and p8, which is activated by several stress agents, is a candidate that deserves being tested. To investigate this hypothesis, we have created by targeted disruption mice lacking the p8 gene. Although p8 7/7 mice develop normally, mouse embryonic ®broblasts (MEFs) showed altered behavior, p8
MEFs growing more rapidly under normal condition and showing increased resistance to apoptosis after adriamycin-induced DNA damage.
Results

Targeted disruption of the p8 gene creates a null mutation
To investigate the function of p8, a null allele was generated in 129/Sv embryonic stem (ES) cells by replacing exon 2 of the p8 gene, which encodes 60% of the coding sequence, with a neomycin-resistance cassette (Figure 1b) . Germline transmission was obtained after injection of these ES cells into C57BL/6 blastocysts. Then, we intercrossed mice heterozygous (p8 +/7 ) for the targeted disruption to produce homozygous ospring (p8 7/7 ). These crosses provided litters of normal size, with living, apparently normal p8 7/7 ospring occurring with a frequency consistent with Mendelian inheritance. p8 de®ciency was veri®ed by RT ± PCR (data not shown) and/or Southern blot analysis (Figure 1d ) and loss of p8 protein expression in the pancreas with acute pancreatitis was veri®ed by Western blot analysis using a p8 polyclonal antibody (Figure 1e ). Given these results and the extensive nature of the deletion, we conclude that this p8 mutation is null. p8 7/7 mice were monitored for evidence of illness or tumor formation for up to 14 months. Peripheral blood examination showed no evidence of abnormalities. Histological sections from several organs, such as liver, lung, intestine, pancreas, testis, brain, kidney and heart were examined and found normal (data not shown).
Growth properties of p8
7/7 cultured MEFs Cultured MEFs were derived from day 14.5 p8 +/+ and p8 7/7 mouse embryos. We established the initial growth characteristics of these mutant cells in vitro. MEFs cells were monitored during no more than six passages. Between passages 2 and 6, p8 7/7 MEFs showed an accelerated growth rate compared to p8 +/+ MEFs ( Figure 2a ). All MEFs showed contact inhibition, but monolayers formed by p8 7/7 MEFs were more crowded than those formed by p8 +/+ cells. We con®rmed that p8-de®cient MEFs grew more rapidly by measuring [ 3 H]thymidine and BrdU incorporation in both p8 +/+ and p8 7/7 MEFs. As expected p8
7/7
MEFs incorporated about twofold more [ 3 H]thymidine ( Figure 2b ) and about 30% more BrdU than their p8 +/+ counterpart ( Figure 2c ). Moreover,¯ow cytometry pro®les of nuclear DNA content revealed that, compared to p8 +/+ MEFs, the number of p8
MEFs was increased in S (14 vs 12%) and G2/M (39 vs 33%) phases (Figure 2f ), con®rming and extending results from the [ 3 H]thymidine and BrdU incorporation experiments. To understand the mechanism of the accelerated growth of p8 7/7 MEFs, we compared in p8 +/+ and p8 7/7 MEF extracts the levels of the cyclin-dependent kinases cdk2 and cdk4 and of cdc2 during the growing phase, using speci®c antibodies. Also, we estimated the intracellular level of the cyclin-dependent kinase inhibitor p27. Results are shown in Figure 2d . p8 7/7 MEFs contained increased amounts of both cdk2 and cdk4, but not of the cdc2. Conversely, the p27 intracellular amount was lower in p8 7/7 MEFs than in p8 +/+ MEFs. In addition, as expected cdk2 and cdk4 activities, which are in part regulated by the cyclin-dependent kinase inhibitor p27, were higher in the p8 7/7 MEFs ( Figure 2e ). Together, these observations may explain, at least in part, the accelerated cell growth observed for p8 7/7 MEFs and strongly suggest that, in vitro, p8 acts as an inhibitor of MEF cell proliferation. Figure 3a ± c, p8 mRNA expression was strongly induced in all cases. These results indicate that p8 is activated in ®broblasts during growth arrest and that it could contribute to cell cycle arrest. To con®rm this hypothesis, we monitored cell growth arrest of p8 +/+ and p8 7/7 MEFs in response to serum withdrawal. As shown in Figure 3d +/+ and p8 7/7 MEFs. Ten thousand p8 7/7 or p8 +/+ MEFs/well were cultivated in a 96-well plate for 24 h and 1 mCi [ 3 H]thymidine was added to the medium. Tritium incorporation was measured after 6 h with a scintillation counter. (c) BrdU incorporation of p8 7/7 and p8 +/+ MEFs. p8 +/+ and p8 7/7 MEFs were incubated with 5-Bromo-2'-deoxy-uridine (BrdU) during 15 min and BrdU incorporation was determined by the 5-Bromo-2'-deoxy-uridine labeling and detection kit (Roche Molecular Biochemicals). BrdU positive cells were visualized and counted with a¯uorescence microscope. (d) Western blot analysis of cdk2, cdk4, cdc2, p27 and b tubulin expression in p8 +/+ and p8 7/7 MEFs. One representative experiment is presented. (e) cdk2 and cdk4 activities in p8 +/+ and p8 7/7 MEFs. The activities of the cdks was assayed by immunoprecipitation kinase assay using histone H1 or glutathione S-transferase-Rb (aa 379 ± 928) as substrates. Quantitation of data from three separate experiments is presented as mean+s.d. cdk2 and cdk4 activity normalized to p8 +/+ MEFs values (100%). F) Flow cytometry analysis. Samples of 5610 5 cells were processed for propidium iodide staining using the reagents obtained as a kit from Coultronics (see Materials and methods) and uorescence analysis was performed in a¯ow-cytometer. The percentage of cells in G1, S and G2/M is indicated. Values were obtained as the mean of two independent experiments 48 h, whereas [ 3 H]thymidine incorporation was only decreased by half in p8 7/7 MEFs, compared to cells grown in 10% FCS. These results demonstrate that p8 participates in cell growth arrest and suggest that its overexpression during arrest, described above, is relevant to that process. 7/7 MEFs are more resistant than p8 +/+ MEFs to apoptosis consecutive to adriamycin-induced DNA damage If DNA damage occurs, cells need to repair their genetic material before resuming progression through the cell cycle. Upon adriamycin treatment that causes chromosomal alterations, cell cycle arrests at the G1/S checkpoint which prevents DNA replication and mitosis to allow DNA repair. However, when DNA lesions are too extensive and exceed the DNA-repair capacity of the cells, cells will switch to an apoptosis program. We monitored apoptosis by TUNEL staining in p8 +/+ and p8 7/7 MEFs, 24 and 48 h after adriamycin treatment (0.33 mM). At the same times, we also measured cell death by Hoescht 33258 staining. Figure 4a ± d indicate that p8 +/+ MEFs are more sensitive to death by apoptosis than p8 7/7 cells as estimated by TUNEL and Hoescht 33258 staining. It was concluded that expression of p8 facilitates cell death by apoptosis, as already reported for other genes that induce cell growth arrest. Interestingly, p8 expression was rapidly induced in response to adriamycin treatment (Figure 4e ). p8 expression facilitates p53 and p21 accumulations in response to adriamycin treatment Since p8 +/+ MEFs are more sensitive than p8
MEFs to adriamycin-induced apoptosis, a program that involves p53, we investigated whether p8 expression in MEFs alters the induction of p53 that follows adriamycin addition to the culture medium. Figure 5 shows that p8 +/+ MEFs express p53 more eciently than MEFs lacking the active p8 gene. We also found that p21, whose induction upon DNA damage is partly dependent on p53, was expressed to higher levels in p8 +/+ than in p8 7/7 MEFs. Hence, p8 is involved in the mechanism of p53 induction that takes place in response to adriamycin-induced DNA damage.
To check whether p8 could aect p53 transactivation, we transfected p8 +/+ and p8 7/7 MEFs with the p53-TA-Luc plasmid, a reporter system whose expression is controlled by a tandem of p53-responsive elements. As shown in Figure 6a , p53 transcriptional activity is indeed four times higher in p8 +/+ MEFs, compared to p8 7/7 MEFs, demonstrating that p8 is involved in the induction of p53 trans-activation. p53 inhibits transcription of the p8 gene, which forms an autoregulatory loop
We investigated whether p53 could in¯uence p8 gene transcription, which would constitute an autoregulatory loop. To this end, we used a construct containing nucleotides from position 71472 to position+36 of the p8 promoter driving the CAT reporter gene (Vasseur et al., 1999b) to transfect p8 +/+ MEFs in the presence of increasing amounts of a p53 expression plasmid (pRc/CMVhp53) or a mutated
7.5
Figure 3 p8 in arrested ®broblasts. (a) One million NIH3T3 cells were plated in 10 cm culture dishes in DMEM medium with 10% FCS. Forty-eight hours later, medium was replaced by DMEM with 0.1% FCS and cells were collected after 6, 12, 18, 24, 30, 36, 42 or 48 h and their RNA prepared. (b) 0.2, 0.5, 1.0, 3.0 and 7.0610 6 NIH3T3 cells were plated in 10 cm culture dishes in DMEM medium with 10% FCS. Forty-eight hours later, cells were collected and their RNA prepared. (c) 10 6 NIH3T3 cells were plated in 10 cm culture dishes in DMEM medium with 10% FCS and cells were collected after 1, 2, 3, 4, 5, 6 or 7 days for RNA puri®cation. Expression of p8 mRNA was measured by Northern blot using a speci®c mouse p8 cDNA as probe. (d (Figure 6b ). Then, we analysed p8 mRNA expression in Val5, a clonal cell line derived from 10.1 cells by stable transfection of the temperature-sensitive p53 mutant (val135) driven by the Harvey sarcoma virus long terminal repeat (Michalovitz et al., 1990) . At the permisive temperature (328C), p8 mRNA was found downregulated compared to its expression at 38.58C (non-permisive temperature) (Figure 6d ). Finally, we controlled that p8 expression did not aect the transcriptional activity of the p8 promoter ( Figure  6c ).
Discussion
p8 expression inhibits cell growth in MEFs
This work provides direct evidence that p8 works in ®broblasts as a negative regulator of proliferation under normal growth conditions, since p8
MEFs grew more rapidly and incorporated more [ 3 H]thymidine and BrdU than p8 +/+ MEFs ( Figure  2a ± c) . Inhibition seems to occur upstream from cyclin-dependent kinases because the intracellular levels and activities of the cdk2 and cdk4 are decreased when p8 is expressed (Figure 2d) . Concomitantly, the cyclin-dependent kinase inhibitor p27 is expressed at a lower level in these cells (Figure 2d ) which may explain at least in part the increased activity of cdk2 and cdk4. Interestingly, p8 expression, which is activated by several stress inductors in almost every cell type (Mallo et al., 1997) , is also induced during cell cycle arrest consecutive to serum withdrawal (Figure 3a) . Also, cell cycle arrest by serum deprivation is more ecient in p8-expressing MEFs than in p8-de®cient MEFs (Figure 3d ). Taken together, these results strongly suggest that p8 is expressed in ®broblasts to promote the arrest of cell growth. Therefore, p8 may be considered as a stress gene regulating cell growth. Implication of stress genes in the regulation of cell cycle progression was already reported. For example, the tumor suppressor gene p53, which is expressed at extremely low levels under normal condition, is strongly activated in response to adverse cellular environment to promote cell cycle arrest and apoptosis (Colman et al., 2000; Amundson et al., 1998) . +/+ MEFs are more sensitive than p8 7/7 MEFs to the apoptosis induced by DNA damage as judged by TUNEL and Hoescht 33258 staining (Figure 4) . Hence, in addition to facilitating cell growth arrest, p8 expression can facilitate cell death by apoptosis. Interestingly, these two mechanisms are already known to be controlled by the transcription factor p53 (Amundson et al., 1998) . It is therefore possible that p8 and p53 are involved into the same regulatory pathway. Without information on which one would be upstream from the other, we ®rst looked whether p8 would regulate p53. As shown in Figure 5 , p53 is expressed at lower level in p8 7/7 MEFs compared to p8 +/+ MEFs in response to adriamycin treatment, which strongly suggests that p8 expression facilitates p53 accumulation in MEFs. In addition, p21, which is a major target gene of p53 after adriamycin treatment (Polyak et al., 1996) , is also present at higher levels in cells producing p8 than in p8 7/7 MEFs, supporting the hypothesis that p8 may contribute to p53 trans-activity.
This link to p53 is an interesting ®nding regarding the positioning of p8 within the cellular regulatory pathways. Cells devoid of wild-type p53 are defective in critical cell cycle checkpoints and have impaired intracellular and extracellular pathways regulating cell growth and programmed cell death (Buckbinder et al., 1995; Dameron et al., 1994; Hartwell and Kastan, 1994; Ko and Prives, 1996) . Inactivation of the p53 tumor suppressor protein, which renders mammalian cells susceptible to oncogenic stimuli and environmental insults that promote growth deregulation and malignant progression, is the most common aberration known to occur in human cancers (Hollstein et al., 1991) . Interestingly, contrary to mice de®cient in p53 that spontaneously develop tumors (Donehower et al.,
1992), none of the p8
7/7 mice developed malignancies during 14 months of observation. Hence, although p8 regulates p53 level, there is enough p53 expressed in the absence of p8 to prevent early tumor formation.
Autoregulatory loop of p8 and p53 in MEFs: p8 increases p53 trans-activation whereas p53 represses p8 transcription After demonstrating that p8 could regulate p53 expression, we checked whether the reverse was possible. In fact, p53 seems to repress expression of the p8 gene as judged by the results of co-transfection experiments shown in Figure 6b . In support of these ®ndings, we found that p8 mRNA is overexpressed in 10.1 ®broblasts, in which both p53 alleles are deleted and are consequently p53-negative (Harvey and Levine, 1991) , compared to NIH3T3 ®broblasts (data not shown). In addition, we analysed p8 mRNA expression in Val5, a clonal cell line derived from 10.1 cells by stable transfection of the temperature-sensitive p53 mutant (val135) driven by the Harvey sarcoma virus long terminal repeat (Michalovitz et al., 1990) . At the permissive temperature (328C), p8 mRNA was found down-regulated compared to its expression at 38.58C (non-permissive temperature) (Figure 6d ). Therefore, p8 and p53 seem to be engaged in an autoregulatory loop. The molecular mechanism by which p53 represses p8 gene transcription remains to be determined. Although p53 is known to be a transcriptional activator of genes involved in cell cycle arrest and apoptosis, it can also be a transcriptional repressor (Pesch et al., 1996; Subbaramaiah et al., 1999; Zhai and Comai, 2000; Zhang et al., 2000) . This inhibition is carried out by direct contact of p53 with TATAbinding proteins (Farmer et al., 1996; Martin et al., 1993; Ragimov et al., 1993; Seto et al., 1992) , which might be the mechanism involved in p8 transcriptional inhibition because a mutated form of p53 was unable to inhibit p8 transcription (Figure 6b ). Finally, p8 overexpression observed in some cancers (Ree et al., 1999; Su et al., 2001 and data not shown) in which p53 is frequently mutated might be due to the loss of the p8/p53 autoregulatory loop.
Concluding remarks p8 appears to play important roles in cell growth regulation and apoptosis since MEFs lacking the p8 active gene show strong alterations in their behavior during normal growth and after adriamycin induced DNA-damage. p8 mRNA expression being induced in ®broblasts in response to growth arrest and p8
7/7
MEFs growing more rapidly, we conclude that p8 participates in the regulation of cell growth arrest. The mechanism of action of p8 remains to be determined. However, alterations in p8 7/7 embryonic ®broblasts of the intracellular levels and activities of cdk2 and cdk4 and of the cyclin-dependent kinase inhibitor p27 may account, at least in part, for increased cell growth. In addition, expression of p8 Figure 5 Expression of p53 and p21 in p8 +/+ and p8 7/7 MEFs after adriamycin treatment. p8 +/+ and p8 7/7 MEFs were treated with adriamycin as described in the legend of Figure 4 and expressions of p53 and p21 were estimated by Western blot analysis after 6, 12 and 24 h. One representative experiment of four is presented. b tubulin expression was used as control p8 effect on cell growth and apoptosis S Vasseur et al modi®es the intracellular level of p53 and its transactivation capacity, suggesting that some eects of p8, particularly those related to apoptosis, may be exerted through this pathway. Finally, the strong link between the expressions of p8 and p53, indicating a complex autoregulatory loop, suggests that p8 is an important regulatory protein that deserves further studies. ) of that plasmid and the pCMV/bgal (control) plasmid. CAT activity was normalized to b-galactosidase activity. (c) p8
+/+ and p8 7/7 MEFs were transfected with the p8-CAT reporter plasmid in combination with the pCMV/bgal (control) plasmid. Twenty-four hours later CAT and b-galactosidase activities were measured. CAT activity was normalized to b-galactosidase activity. All experiments were conducted in triplicate and results expressed as mean+s.d. (d) p8 mRNA expression was analysed by Northern blot in Val5 cells which express a temperature-sensitive p53. Cells were grown at permissive (32.08C) or non-permissive (38.58C) temperature. The 28S RNA was used as control. (e) An integrative view of the autoregulatory loop of p8 and p53 showing the positive and negative eects on the p8 gene promoter of the cellular stress and p53, respectively
Materials and Methods
Targeted disruption of the mouse p8 gene and production of p8 7/7 and p8 +/+ embryonic fibroblasts
The p8 gene was modi®ed by homologous recombination in embryonic stem (ES) cells according to published procedures (Kuhbandner et al., 2000) . Brie¯y, the linearized targeting vector (see Figure 1 ) was electroporated into R1 ES cells, and G418/ganciclovir-resistant clones were screened for correct integrants by PCR using primers A (5'ATAATGT-TATCCTCTCTGGAGTCT3') and B (5'GCCTGAAGAAC-GAGATCAGC3'), which amplify a 4138 bp fragment of the targeted p8 locus. Five PCR-positive clones were veri®ed by Southern blot hybridization of BstEII-digested DNA with a 650 bp fragment of the p8 gene. Three independent ES cell clones were injected into C57BL/6 blastocysts to generate chimeric mice that transmitted the modi®ed p8 allele to the germ line. Genotype analysis was done by PCR and/or Southern blot with genomic DNA prepared from tail biopsies of 10-day-old pups. Heterozygous mice for the mutated p8 allele were obtained and used in breeding experiments to generate mice homozygous (
) for the disruption of p8. Primary embryo ®broblasts were isolated from 14.5-day-old mouse embryos following standard protocols (Harvey et al., 1993) . p8 genotypes of cultured cells were determined by PCR. Cells were grown in Dulbecco's modi®ed Eagle's medium supplemented with 10% fetal calf serum and used after a maximum of six passages. One hundred mg of total pancreatic protein from pancreas of p8 +/+ and p8 7/7 mice suering from pancreatitis was separated with standard procedures on 12.5% SDS ± PAGE using the Mini Protean System (Bio-Rad) and transferred to nitrocellulose membrane (Sigma). Expression of p8 was estimated by Western blot using a polyclonal antibody raised against human p8 (Vasseur et al., 1999a) .
Cell proliferation
One hundred thousand of each cell line at passage 3 were plated in a series of 35 mm culture dishes. The cell number was estimated daily in triplicate (from 1 to 6 days) in an hemacytometer.
p8 mRNA expression in arrested fibroblasts p8 mRNA expression was measured in NIH3T3 cells following three dierent protocols of growth arrest. Firstly, 1610 6 NIH3T3 cells were plated in 10 cm culture dishes in DMEM medium with 10% FCS. Forty-eight hours later, medium was replaced by DMEM with 0.1% FCS and cells were collected after dierent times (6, 12, 18, 24, 30, 36, 42 and 48 h) . Total RNA was puri®ed using the TRIzol reagent following instructions of the manufacturer (Gibco-BRL). Secondly, 0.2, 0.5, 1.0, 3.0 and 7.0610 6 NIH3T3 cells were plated in 10 cm culture dishes in DMEM medium with 10% FCS. Forty eight hours later, cells were collected and RNA prepared as described above. Thirdly, 1610 6 NIH3T3 cells were plated in 10 cm culture dishes in DMEM medium with 10% FCS and cells were collected after dierent times for RNA puri®cation as described above. Culture medium was changed every other days. In the ®rst protocol, cell growth arrest was induced by growth factors withdrawal, whereas in the second and third protocols it was induced by contact inhibition. Expression of p8 mRNA was measured by Northern blot using a speci®c mouse p8 cDNA as probe (Vasseur et al., 1999b) .
p8 mRNA expression in adriamycin-treated fibroblasts
One million p8 +/+ MEFs were plated in 10 cm culture dishes in DMEM medium with 10% FCS. Forty-eight hours later cells were treated with 0.33 mM adriamycin and p8 mRNA expression was measured by Northern blot as described above.
p8 mRNA expression in the p53 temperature-sensitive mutant Val5 fibroblasts
The Val5 ®broblasts which express a p53 temperature-sensitive mutant (Harvey and Levine, 1991) were used to test the ability of p53 to control expression of the p8 mRNA under normal conditions of culture but incubated at 38.58C (the non-permissive temperature) or at 328C (the permissive temperature) which favors expression of wild-type p53. p8 mRNA expression was measured by Northern blot as described above. 
BrdU incorporation in p8
7/7 and p8 +/+ MEFs p8 +/+ and p8 7/7 MEFs were incubated with 5-Bromo-2'-deoxy-uridine (BrdU) during 15 min and BrdU incorporation was determined by the 5-Bromo-2'-deoxy-uridine labeling and detection kit following instructions of the manufacturer (Roche Molecular Biochemicals). BrdU positive cells were visualized and counted with a¯uorescence microscope.
Flow cytometry analysis
For¯ow cytometry studies, duplicate samples of 5610 5 p8 +/+ and p8 7/7 MEFs were processed for propidium iodide staining as follows: cells were harvested from culture and permeabilized in 500 ml of 50 mg/ml propidium iodide, 0.05% Nonidet P-40, 4 KU/ml RNase, in PBS. Reagents were obtained as a kit from Coultronics France (Margency, France) and used according to recommendations. After vortexing, samples were allowed to equilibrate at room temperature in the dark for at least 1 h before analysis. Propidium iodide¯uorescence analysis was performed in ā ow-cytometer (EPICS, Coulter Corporation). Hoescht 33258 staining p8 +/+ and p8 7/7 MEFs were treated with 0.33 mM adriamycin and nuclear morphology was determined by Hoescht 33258 staining after 24 and 48 h following instructions of the manufacturer (Sigma). Nuclear fragmentation was visualized and counted with a¯uorescence microscope.
Cell transfection and gene reporter assays
To test the p53 trans-acting activity in p8 +/+ and p8
7/7
MEFs we used the p53-TA-Luc plasmid (Clontech) whose expression is controlled by a tandem of p53-responsive elements. One hundred thousand MEFs/well were cultivated in a 6-well plate for 24 h. Then, cells were transfected with p53-TA-Luc plasmid in combination with the pCMV/bgal (to control transfection eciency) using the Fugene reagent according to the manufacturer's protocol (Roche Molecular Biochemicals). Twenty-four hours later we performed the Luciferase assay using the Luciferase Assay System (Promega) following instructions of the manufacturer (n=6). b-galactosidase assay was performed as previously described (Vasseur et al., 1999b) . The Luciferase activity was normalized to b-galactosidase activity.
In other experiments, 1610 5 p8 +/+ MEFs were cultivated in a 6-well plate for 24 h, then transiently transfected with 1 mg of p8-CAT reporter plasmid together with dierent amounts of a p53 expression plasmid (pRc/CMVhp53) or a mutated form (pRc/CMVhp53 mut22/23 ) and 1 mg of pCMV/bgal plasmid (to control transfection eciency) using the Fugene reagent according to the manufacturer's protocol (Roche Molecular Biochemicals). The p-1471/+37p8-CAT promoter construct (Vasseur et al., 1999b) was used in CAT reporter assays. CAT activity was measured as described previously (Vasseur et al., 1999b) . Cell extracts were prepared using the reporter lysis buer (Promega) 24 h after transfection. CAT activity was determined using the phase extraction procedure (Seed and Sheen, 1988) and b-galactosidase assay was performed essentially as described above. The CAT activity was normalized to b-galactosidase activity (n=6).
We also tested the eect of p8 expression on p8 transcription. One hundred thousand p8 +/+ and p8
MEFs/well were cultivated in a 6-well plate for 24 h. Then, cells were transfected with the p8-CAT plasmid in combination with the pCMV/bgal plasmid (to control transfection eciency) using the Fugene reagent according to the manufacturer's protocol (Roche Molecular Biochemicals). Twenty-four hours later CAT activity was measured as described above. The CAT activity was normalized to bgalactosidase activity (n=6).
SDS ± PAGE and Western-blot analysis
One hundred mg of total cell protein was separated as described (Sambrook et al., 1989) on 12.5% SDS ± PAGE using the Mini Protean System (Bio-Rad) and transferred to nitrocellulose membrane (Sigma). The intracellular levels of p53, p21, cdk2, cdk4, cdc2, p27 and b tubulin were estimated by Western blot using speci®c antibodies. The antibodies used were the anti-p53 polyclonal antibody (FL-393), the anti-p21 polyclonal antibody (C-19), the anti-cdk2 polyclonal antibody (M2), the anticdk4 polyclonal antibody (C-22), the p27 polyclonal antibody (N-20), the anti-cdc2 monoclonal antibody (17) and the monoclonal anti-b tubulin antibody (D-10). All antibodies were purchased from Santa Cruz Biotechnology, Inc.
Immunoprecipitation and kinase assays p8 +/+ and p8 7/7 MEFs were grown in 100-mm culture dishes and cdk2 and cdk4 activities were measured following lysis in 1 ml of buer containing 20 mM HEPES (pH 7.4), 150 mM NaCl, 0.5% Nonidet P-40, 10 mg/ml aprotinin and 10 mg/ml leupeptin. Clari®ed extracts were incubated with 1.5 mg of anti-cdk2 antibody (Santa Cruz Biotechnology; M2) or 1.5 mg of anti-cdk4 antibody (Santa Cruz Biotechnology; C-22) and immune complexes were recovered with protein ASepharose, washed twice with lysis buer and once with kinase buer (25 mM HEPES, pH 7.4, 10 mM MgCl 2 , 1 mM EGTA). Pellets were resuspended in 25 ml of kinase buer containing either 4 mg histone H1 (Boehringer Mannheim) or glutathione S-transferase-Rb (aa 379 ± 928) to measure cdk2 and cdk4 activity, respectively. Reactions were terminated at 10 min by the addition of sample buer and boiling. Kinase reactions were analysed by SDS ± PAGE and dried gels were exposed to an X-ray ®lm to visualize proteins. Reactions were quanti®ed using a PhosphorImager (Molecular Dynamics).
